{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:40:01Z","timestamp":1790959201473,"version":"4.1.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-024-02930-7","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T10:08:25Z","timestamp":1726654105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["PEGylated pH-Responsive Liposomes for Enhancing the Intracellular Uptake and Cytotoxicity of Paclitaxel in MCF-7 Breast Cancer Cells"],"prefix":"10.1208","volume":"25","author":[{"given":"Harsh P.","family":"Nijhawan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Shyamsundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bala","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1620-0547","authenticated-orcid":false,"given":"Khushwant S.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"key":"2930_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel Mph","year":"2023","unstructured":"Siegel Mph RL, Miller KD, Sandeep N, Mbbs W, Ahmedin J, Dvm J, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin."},{"key":"2930_CR2","doi-asserted-by":"publisher","unstructured":"Buchheit JT, Schacht D, Kulkarni SA. Update on management of ductal carcinoma in situ. Clin Breast Cancer. 2023. https:\/\/doi.org\/10.1016\/j.clbc.2023.12.010.","DOI":"10.1016\/j.clbc.2023.12.010"},{"key":"2930_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.critrevonc.2011.01.010","volume":"80","author":"NS El Saghir","year":"2011","unstructured":"El Saghir NS, Tfayli A, Hatoum HA, Nachef Z, Dinh P, Awada A. Treatment of metastatic breast cancer: State-of-the-art, subtypes and perspectives. Crit Rev Oncol Hematol. 2011;80:433\u201349.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2930_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ajps.2016.07.007","volume":"12","author":"M Sun","year":"2017","unstructured":"Sun M, Gao Y, Zhu Z, Wang H, Han C, Yang X, et al. A systematic in vitro investigation on poly-arginine modified nanostructured lipid carrier: Pharmaceutical characteristics, cellular uptake, mechanisms and cytotoxicity. Asian J Pharm Sci. 2017;12:51\u20138.","journal-title":"Asian J Pharm Sci"},{"key":"2930_CR5","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/ijc.30529","volume":"140","author":"D Maksimovic-Ivanic","year":"2017","unstructured":"Maksimovic-Ivanic D, Fagone P, McCubrey J, Bendtzen K, Mijatovic S, Nicoletti F. HIV-protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives? Int J Cancer. 2017;140:1713\u201326.","journal-title":"Int J Cancer"},{"key":"2930_CR6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jconrel.2012.09.006","volume":"163","author":"\u0160 Koudelka","year":"2012","unstructured":"Koudelka \u0160, Tur\u00e1nek J. Liposomal paclitaxel formulations. J Control Release. 2012;163:322\u201334.","journal-title":"J Control Release"},{"key":"2930_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ejpb.2004.06.009","volume":"59","author":"JA Zhang","year":"2005","unstructured":"Zhang JA, Anyarambhatla G, Ma L, Ugwu S, Xuan T, Sardone T, et al. Development and characterization of a novel Cremophor\u00ae EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur J Pharm Biopharm. 2005;59:177\u201387.","journal-title":"Eur J Pharm Biopharm"},{"key":"2930_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i4.10","volume":"26","author":"S Singh","year":"2009","unstructured":"Singh S, Dash AK. Paclitaxel in Cancer Treatment: Perspectives and Prospects of its Delivery Challenges. Crit Rev Trade Ther Drug Carrier Syst. 2009;26:333\u201372.","journal-title":"Crit Rev Trade Ther Drug Carrier Syst"},{"key":"2930_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11671-021-03628-6","volume":"16","author":"S Gavas","year":"2021","unstructured":"Gavas S, Quazi S, Karpi\u0144ski TM. Nanoparticles for Cancer Therapy: Current Progress and Challenges. Nanoscale Res Lett. 2021;16:1\u201321.","journal-title":"Nanoscale Res Lett"},{"key":"2930_CR10","doi-asserted-by":"publisher","first-page":"100103","DOI":"10.1016\/j.onano.2022.100103","volume":"8","author":"H Raut","year":"2022","unstructured":"Raut H, Jadhav C, Shetty K, Laxane N, Nijhawan HP, Rao GK, et al. Sorafenib tosylate novel drug delivery systems: Implications of nanotechnology in both approved and unapproved indications. OpenNano. 2022;8:100103.","journal-title":"OpenNano"},{"key":"2930_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2020.06.022","volume":"156","author":"N Filipczak","year":"2020","unstructured":"Filipczak N, Pan J, Yalamarty SSK, Torchilin VP. Recent advancements in liposome technology. Adv Drug Deliv Rev. 2020;156:4\u201322.","journal-title":"Adv Drug Deliv Rev"},{"key":"2930_CR12","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2217\/nnm.13.118","volume":"8","author":"PP Deshpande","year":"2013","unstructured":"Deshpande PP, Biswas S, Torchilin VP. Current trends in the use of liposomes for tumor targeting. Nanomedicine (Lond). 2013;8:1509\u201328.","journal-title":"Nanomedicine (Lond)"},{"key":"2930_CR13","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ajps.2017.05.008","volume":"12","author":"L Wang","year":"2017","unstructured":"Wang L. Preparation and in vitro evaluation of an acidic environment-responsive liposome for paclitaxel tumor targeting. Asian J Pharm Sci. 2017;12:470\u20137.","journal-title":"Asian J Pharm Sci"},{"key":"2930_CR14","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.3390\/cancers14071741","volume":"14","author":"JJ Milligan","year":"2022","unstructured":"Milligan JJ, Saha S. A nanoparticle\u2019s journey to the tumor: Strategies to overcome first-pass metabolism and their limitations. Cancers. 2022;14:1741.","journal-title":"Cancers"},{"key":"2930_CR15","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1016\/j.bbamem.2012.06.019","volume":"1818","author":"K Nakamura","year":"2012","unstructured":"Nakamura K, Yamashita K, Itoh Y, Yoshino K, Nozawa S, Kasukawa H. Comparative studies of polyethylene glycol-modified liposomes prepared using different PEG-modification methods. Biochim Biophys Acta (BBA) - Biomembr. 2012;1818:2801\u20137.","journal-title":"Biochim Biophys Acta (BBA) - Biomembr"},{"key":"2930_CR16","doi-asserted-by":"publisher","unstructured":"Bhargave H, Nijhawan H, Yadav KS. PEGylated Erlotinib HCl Injectable Nanoformulation for Improved Bioavailability. AAPS PharmSciTech. 2023;24. https:\/\/doi.org\/10.1208\/s12249-023-02560-5.","DOI":"10.1208\/s12249-023-02560-5"},{"key":"2930_CR17","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3390\/nano10040787","volume":"10","author":"SY Fam","year":"2020","unstructured":"Fam SY, Chee CF, Yong CY, Ho KL, Mariatulqabtiah AR, Tan WS. Stealth coating of nanoparticles in drug-delivery systems. Nanomaterials. 2020;10:787.","journal-title":"Nanomaterials"},{"key":"2930_CR18","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s13346-019-00631-4","volume":"9","author":"Z Hussain","year":"2019","unstructured":"Hussain Z, Khan S, Imran M, Sohail M, Shah SWA, de Matas M. PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution. Drug Deliv Transl Res. 2019;9:721\u201334.","journal-title":"Drug Deliv Transl Res"},{"key":"2930_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jconrel.2010.08.027","volume":"148","author":"F Danhier","year":"2010","unstructured":"Danhier F, Feron O, Pr\u00e9at V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release. 2010;148:135\u201346.","journal-title":"J Control Release"},{"key":"2930_CR20","doi-asserted-by":"publisher","first-page":"103701","DOI":"10.1016\/j.drudis.2023.103701","volume":"28","author":"HP Nijhawan","year":"2023","unstructured":"Nijhawan HP, Prabhakar B, Misra A, Yadav KS. Fragmented antibodies in non-small cell lung cancer: A novel nano-engineered delivery system for detection and treatment of cancer. Drug Discov Today. 2023;28:103701.","journal-title":"Drug Discov Today"},{"key":"2930_CR21","first-page":"1","volume":"23","author":"J Wang","year":"2021","unstructured":"Wang J, Gong J, Wei Z. Strategies for Liposome Drug Delivery Systems to Improve Tumor Treatment Efficacy. AAPS PharmSciTech. 2021;23:1\u201314.","journal-title":"AAPS PharmSciTech."},{"key":"2930_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/jps.23773","volume":"103","author":"JC Kraft","year":"2014","unstructured":"Kraft JC, Freeling JP, Wang Z, Ho RJY. Emerging Research and Clinical Development Trends of Liposome and Lipid Nanoparticle Drug Delivery Systems. J Pharm Sci. 2014;103:29\u201352.","journal-title":"J Pharm Sci"},{"key":"2930_CR23","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.3390\/pharmaceutics14061128","volume":"14","author":"H Alrbyawi","year":"2022","unstructured":"Alrbyawi H, Poudel I, Annaji M, Boddu SHS, Arnold RD, Tiwari AK, et al. pH-Sensitive liposomes for enhanced cellular uptake and cytotoxicity of daunorubicin in melanoma (B16-BL6) cell lines. Pharmaceutics. 2022;14:1128.","journal-title":"Pharmaceutics"},{"key":"2930_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.colsurfb.2016.11.042","volume":"151","author":"Y Fan","year":"2017","unstructured":"Fan Y, Chen C, Huang Y, Zhang F, Lin G. Study of the pH-sensitive mechanism of tumor-targeting liposomes. Colloids Surf B Biointerfaces. 2017;151:19\u201325.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2930_CR25","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.addr.2003.10.039","volume":"56","author":"MA Yessine","year":"2004","unstructured":"Yessine MA, Leroux JC. Membrane-destabilizing polyanions: interaction with lipid bilayers and endosomal escape of biomacromolecules. Adv Drug Deliv Rev. 2004;56:999\u20131021.","journal-title":"Adv Drug Deliv Rev"},{"key":"2930_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3109\/10717544.2014.882469","volume":"22","author":"SR Paliwal","year":"2015","unstructured":"Paliwal SR, Paliwal R, Vyas SP. A review of mechanistic insight and application of pH-sensitive liposomes in drug delivery. Drug Deliv. 2015;22:231\u201342.","journal-title":"Drug Deliv"},{"key":"2930_CR27","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3390\/polym10101127","volume":"10","author":"Y Zhai","year":"2018","unstructured":"Zhai Y, Zhou X, Zhang Z, Zhang L, Wang D, Wang X, et al. Design, synthesis, and characterization of schiff base bond-linked pH-responsive doxorubicin prodrug based on functionalized mPEG-PCL for targeted cancer therapy. Polymers. 2018;10:1127.","journal-title":"Polymers"},{"key":"2930_CR28","doi-asserted-by":"publisher","first-page":"101505","DOI":"10.1016\/j.jddst.2020.101505","volume":"56","author":"U Hani","year":"2020","unstructured":"Hani U, Rahamathulla M, Osmani RA, Kumar HY, Urolagin D, Ansari MY, et al. Recent advances in novel drug delivery systems and approaches for management of breast cancer: A comprehensive review. J Drug Deliv Sci Technol. 2020;56:101505.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2930_CR29","doi-asserted-by":"crossref","unstructured":"Bhargave H, Nijhawan H, Yadav KS. PEGylated Erlotinib HCl Injectable Nanoformulation for Improved Bioavailability. AAPS PharmSciTech [Internet]. 2023 [cited 2024 Mar 24];24. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37038015\/.","DOI":"10.1208\/s12249-023-02560-5"},{"key":"2930_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-1-4939-6646-2_3","volume":"1530","author":"B Aryasomayajula","year":"2017","unstructured":"Aryasomayajula B, Salzano G, Torchilin VP. Multifunctional liposomes. Methods Mol Biol. 2017;1530:41\u201361.","journal-title":"Methods Mol Biol"},{"key":"2930_CR31","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/10837450.2023.2251148","volume":"28","author":"KS Yadav","year":"2023","unstructured":"Yadav KS, Raut HC, Nijhawan HP. Inhalable spray-dried polycaprolactone-based microparticles of Sorafenib Tosylate with promising efficacy on A549 cells. Pharm Dev Technol. 2023;28:755\u201367.","journal-title":"Pharm Dev Technol"},{"key":"2930_CR32","doi-asserted-by":"publisher","first-page":"100630","DOI":"10.1016\/j.xcrm.2022.100630","volume":"3","author":"B Kass","year":"2022","unstructured":"Kass B, Schemmert S, Zafiu C, Pils M, Bannach O, Kutzsche J, et al. A\u03b2 oligomer concentration in mouse and human brain and its drug-induced reduction ex vivo. Cell Rep Med. 2022;3:100630.","journal-title":"Cell Rep Med"},{"key":"2930_CR33","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.1039\/c3tb20906g","volume":"1","author":"E Jang","year":"2013","unstructured":"Jang E, Lim EK, Choi Y, Kim E, Kim HO, Kim DJ, et al. \u03c0-Hyaluronan nanocarriers for CD44-targeted and pH-boosted aromatic drug delivery. J Mater Chem B. 2013;1:5686\u201393.","journal-title":"J Mater Chem B"},{"key":"2930_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/8234712","volume":"2017","author":"TL Nguyen","year":"2017","unstructured":"Nguyen TL, Nguyen TH, Nguyen DH. Development and in vitro evaluation of liposomes using soy lecithin to encapsulate paclitaxel. Int J Biomater. 2017;2017:1.","journal-title":"Int J Biomater"},{"key":"2930_CR35","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1208\/s12249-010-9519-4","volume":"11","author":"KS Yadav","year":"2010","unstructured":"Yadav KS, Sawant KK. Modified nanoprecipitation method for preparation of cytarabine-loaded PLGA nanoparticles. AAPS PharmSciTech. 2010;11:1456.","journal-title":"AAPS PharmSciTech"},{"key":"2930_CR36","doi-asserted-by":"publisher","first-page":"105026","DOI":"10.1016\/j.ejps.2019.105026","volume":"138","author":"IY Wu","year":"2019","unstructured":"Wu IY, Bala S, \u0160kalko-Basnet N, di Cagno MP. Interpreting non-linear drug diffusion data: Utilizing Korsmeyer-Peppas model to study drug release from liposomes. Eur J Pharm Sci. 2019;138:105026.","journal-title":"Eur J Pharm Sci"},{"key":"2930_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0168-3659(87)90035-6","volume":"5","author":"PL Ritger","year":"1987","unstructured":"Ritger PL, Peppas NA. A simple equation for description of solute release. II Fickian and anomalous release from swellable devices. J Control Release. 1987;5:37\u201342.","journal-title":"J Control Release"},{"key":"2930_CR38","first-page":"110","volume":"60","author":"NA Peppas","year":"1985","unstructured":"Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985;60:110\u20131.","journal-title":"Pharm Acta Helv"},{"key":"2930_CR39","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7897\/2230-8407.0812245","volume":"8","author":"MP Paarakh","year":"2018","unstructured":"Paarakh MP, Jose PA, Setty C, Peterchristoper GV. Release kinetics \u2013 Concepts and applications. Int J Pharm Res Technol (IJPRT). 2018;8:12\u201320.","journal-title":"Int J Pharm Res Technol (IJPRT)"},{"key":"2930_CR40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.biopha.2014.11.025","volume":"69","author":"C Shi","year":"2015","unstructured":"Shi C, Gao F, Gao X, Liu Y. A novel anti-VEGF165 monoclonal antibody-conjugated liposomal nanocarrier system: Physical characterization and cellular uptake evaluation in vitro and in vivo. Biomed Pharmacother. 2015;69:191\u2013200.","journal-title":"Biomed Pharmacother"},{"key":"2930_CR41","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3109\/02652048.2011.615949","volume":"28","author":"KS Yadav","year":"2011","unstructured":"Yadav KS, Jacob S, Sachdeva G, Chuttani K, Mishra AK, Sawant KK. Long circulating PEGylated PLGA nanoparticles of cytarabine for targeting leukemia. J Microencapsul. 2011;28:729\u201342.","journal-title":"J Microencapsul"},{"key":"2930_CR42","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1080\/00914037.2022.2135514","volume":"73","author":"K Kale","year":"2024","unstructured":"Kale K, Fulfager A, Juvale K, Yadav KS. Long circulating polymeric nanoparticles of gemcitabine HCl using PLGA-PEG-PPG-PEG block co-polymer. Int J Polym Mater Polym Biomater. 2024;73:176\u201389.","journal-title":"Int J Polym Mater Polym Biomater"},{"key":"2930_CR43","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1016\/j.bmcl.2013.02.094","volume":"23","author":"TVT Le","year":"2013","unstructured":"Le TVT, Suh JH, Kim N, Park HJ. In silico identification of poly(ADP-ribose)polymerase-1 inhibitors and their chemosensitizing effects against cisplatin-resistant human gastric cancer cells. Bioorg Med Chem Lett. 2013;23:2642\u20136.","journal-title":"Bioorg Med Chem Lett"},{"key":"2930_CR44","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1515\/epoly-2020-0064","volume":"20","author":"TD Carrillo-Castillo","year":"2020","unstructured":"Carrillo-Castillo TD, Castro-Carmona JS, Luna-Velasco A, Zaragoza-Contreras EA. PH-responsive polymer micelles for methotrexate delivery at tumor microenvironments. E-Polymers. 2020;20:624\u201335.","journal-title":"E-Polymers"},{"key":"2930_CR45","doi-asserted-by":"publisher","first-page":"104571","DOI":"10.1016\/j.jddst.2023.104571","volume":"86","author":"P Verma","year":"2023","unstructured":"Verma P, Yadav KS. Quality by Design (QbD) enabled and Box-Behnken design assisted approach for formulation of tranexamic acid loaded stratum corneum lipid liposomes. J Drug Deliv Sci Technol. 2023;86:104571.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2930_CR46","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.2217\/nnm-2023-0141","volume":"18","author":"P Verma","year":"2023","unstructured":"Verma P, Singh RK, Wadhwa A, Prabhakar B, Yadav KS. Bimatoprost-loaded lipidic nanoformulation development using quality by design: liposomes versus solid lipid nanoparticles in intraocular pressure reduction. Nanomedicine. 2023;18:1815\u201337. https:\/\/doi.org\/10.2217\/nnm-2023-0141.","journal-title":"Nanomedicine"},{"key":"2930_CR47","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1080\/03639045.2018.1508222","volume":"44","author":"M Tarantash","year":"2018","unstructured":"Tarantash M, Nosrati H, Kheiri Manjili H, Baradar KA. Preparation, characterization and in vitro anticancer activity of paclitaxel conjugated magnetic nanoparticles. Drug Dev Ind Pharm. 2018;44:1895\u2013903.","journal-title":"Drug Dev Ind Pharm"},{"key":"2930_CR48","doi-asserted-by":"publisher","first-page":"116842","DOI":"10.1016\/j.molliq.2021.116842","volume":"340","author":"SR Son","year":"2021","unstructured":"Son SR, An J, Choi JW, Park J, Park CB, Lee JH. Hierarchical self-constructed biomolecular nanolayers comprising cholesterol and cholesteryl hemisuccinate for automatic alignment of liquid crystals. J Mol Liq. 2021;340:116842.","journal-title":"J Mol Liq"},{"key":"2930_CR49","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1007\/s12221-018-8037-y","volume":"19","author":"M Khashi","year":"2018","unstructured":"Khashi M, Hassanajili S, Golestaneh SI. Electrospun poly-lactic acid\/chitosan nanofibers loaded with paclitaxel for coating of a prototype polymeric stent. Fibers Polym. 2018;19:1444\u201353.","journal-title":"Fibers Polym"},{"key":"2930_CR50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ijpharm.2017.12.047","volume":"538","author":"C Caddeo","year":"2018","unstructured":"Caddeo C, Pucci L, Gabriele M, Carbone C, Fern\u00e0ndez-Busquets X, Valenti D, et al. Stability, biocompatibility and antioxidant activity of PEG-modified liposomes containing resveratrol. Int J Pharm. 2018;538:40\u20137.","journal-title":"Int J Pharm"},{"key":"2930_CR51","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.addr.2018.07.002","volume":"132","author":"P Davoodi","year":"2018","unstructured":"Davoodi P, Lee LY, Xu Q, Sunil V, Sun Y, Soh S, et al. Drug delivery systems for programmed and on-demand release. Adv Drug Deliv Rev. 2018;132:104\u201338.","journal-title":"Adv Drug Deliv Rev"},{"key":"2930_CR52","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/jlb.54.6.513","volume":"54","author":"SM Moghimi","year":"1993","unstructured":"Moghimi SM, Hedeman H, Christy NM, Illum L, Davis SS. Enhanced hepatic clearance of intravenously administered sterically stabilized microspheres in zymosan-stimulated rats. J Leukoc Biol. 1993;54:513\u20137.","journal-title":"J Leukoc Biol"},{"key":"2930_CR53","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2146\/ajhp070097","volume":"64","author":"DF Driscoll","year":"2007","unstructured":"Driscoll DF. Globule-size distribution in injectable 20% lipid emulsions: Compliance with USP requirements. Am J Health Syst Pharm. 2007;64:2032\u20136.","journal-title":"Am J Health Syst Pharm"},{"key":"2930_CR54","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ejps.2012.12.006","volume":"48","author":"SD Steichen","year":"2013","unstructured":"Steichen SD, Caldorera-Moore M, Peppas NA. A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. Eur J Pharm Sci. 2013;48:416.","journal-title":"Eur J Pharm Sci"},{"key":"2930_CR55","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jconrel.2013.09.013","volume":"172","author":"MJ Ernsting","year":"2013","unstructured":"Ernsting MJ, Murakami M, Roy A, Li SD. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. J Control Release. 2013;172:782\u201394.","journal-title":"J Control Release"},{"key":"2930_CR56","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.3390\/polym14224905","volume":"14","author":"FL Campos","year":"2022","unstructured":"Campos FL, de Alc\u00e2ntara Lemos J, Oda CMR, de Oliveira Silva J, Fernandes RS, Miranda SEM, et al. Irinotecan-loaded polymeric micelles as a promising alternative to enhance antitumor efficacy in colorectal cancer therapy. Polymers. 2022;14:4905.","journal-title":"Polymers."},{"key":"2930_CR57","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.biomaterials.2016.01.061","volume":"85","author":"M Kanamala","year":"2016","unstructured":"Kanamala M, Wilson WR, Yang M, Palmer BD, Wu Z. Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review. Biomaterials. 2016;85:152\u201367.","journal-title":"Biomaterials"},{"key":"2930_CR58","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jconrel.2007.12.017","volume":"126","author":"S Ganta","year":"2008","unstructured":"Ganta S, Devalapally H, Shahiwala A, Amiji M. A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Release. 2008;126:187\u2013204.","journal-title":"J Control Release"},{"key":"2930_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0005-2736(94)90325-5","volume":"1193","author":"K Kono","year":"1994","unstructured":"Kono K, Zenitani K, Takagishi T. Novel pH-sensitive liposomes: liposomes bearing a poly(ethylene glycol) derivative with carboxyl groups. Biochim Biophys Acta (BBA) - Biomembr. 1994;1193:1\u20139.","journal-title":"Biochim Biophys Acta (BBA) - Biomembr"},{"key":"2930_CR60","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ajps.2013.11.002","volume":"8","author":"X Liu","year":"2013","unstructured":"Liu X, Huang G. Formation strategies, mechanism of intracellular delivery and potential clinical applications of pH-sensitive liposomes. Asian J Pharm Sci. 2013;8:319\u201328.","journal-title":"Asian J Pharm Sci"},{"key":"2930_CR61","doi-asserted-by":"publisher","first-page":"105172","DOI":"10.1016\/j.jddst.2023.105172","volume":"90","author":"P Jayapriya","year":"2023","unstructured":"Jayapriya P, Pardhi E, Vasave R, Guru SK, Madan J, Mehra NK. A review on Stimuli-pH responsive liposomal formulation in cancer therapy. J Drug Deliv Sci Technol. 2023;90:105172.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2930_CR62","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0005-2736(99)00186-8","volume":"1463","author":"IM Hafez","year":"2000","unstructured":"Hafez IM, Cullis PR. Cholesteryl hemisuccinate exhibits pH sensitive polymorphic phase behavior. Biochim Biophys Acta Biomembr. 2000;1463:107\u201314.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"2930_CR63","first-page":"501","volume":"4","author":"H Danafar","year":"2014","unstructured":"Danafar H, Davaran S, Rostamizadeh K, Valizadeh H, Hamidi M. Biodegradable m-PEG\/PCL core-shell micelles: preparation and characterization as a sustained release formulation for curcumin. Adv Pharm Bull. 2014;4:501.","journal-title":"Adv Pharm Bull"},{"key":"2930_CR64","doi-asserted-by":"publisher","first-page":"e1450","DOI":"10.1002\/wnan.1450","volume":"9","author":"Y Lee","year":"2017","unstructured":"Lee Y, Thompson DH. Stimuli-responsive liposomes for drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017;9:e1450.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"2930_CR65","doi-asserted-by":"publisher","first-page":"623760","DOI":"10.3389\/fonc.2021.623760","volume":"11","author":"MS Franco","year":"2021","unstructured":"Franco MS, Gomes ER, Roque MC, Oliveira MC. Triggered drug release from liposomes: exploiting the outer and inner tumor environment. Front Oncol. 2021;11:623760.","journal-title":"Front Oncol"},{"key":"2930_CR66","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s11814-008-0202-3","volume":"25","author":"SM Jo","year":"2008","unstructured":"Jo SM, Xia Y, Lee HY, Kim YC, Kim JC. Liposomes incorporating hydrophobically modified glucose oxidase. Korean J Chem Eng. 2008;25:1221\u20135.","journal-title":"Korean J Chem Eng"},{"key":"2930_CR67","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s11745-008-3223-0","volume":"43","author":"SM Jo","year":"2008","unstructured":"Jo SM, Lee HY, Kim JC. Glucose-sensitive liposomes incorporating hydrophobically modified glucose oxidase. Lipids. 2008;43:937\u201343.","journal-title":"Lipids"},{"key":"2930_CR68","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/pharmaceutics14010129","volume":"14","author":"H Shah","year":"2022","unstructured":"Shah H, Madni A, Khan MM, Ahmad FUD, Jan N, Khan S, et al. pH-responsive liposomes of dioleoyl phosphatidylethanolamine and cholesteryl hemisuccinate for the enhanced anticancer efficacy of cisplatin. Pharmaceutics. 2022;14:129.","journal-title":"Pharmaceutics."},{"key":"2930_CR69","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.chemphyslip.2016.10.005","volume":"201","author":"A Jain","year":"2016","unstructured":"Jain A, Jain SK. In vitro release kinetics model fitting of liposomes: An insight. Chem Phys Lipids. 2016;201:28\u201340.","journal-title":"Chem Phys Lipids"},{"key":"2930_CR70","doi-asserted-by":"publisher","first-page":"120051","DOI":"10.1016\/j.ijpharm.2020.120051","volume":"592","author":"S Maritim","year":"2021","unstructured":"Maritim S, Boulas P, Lin Y. Comprehensive analysis of liposome formulation parameters and their influence on encapsulation, stability and drug release in glibenclamide liposomes. Int J Pharm. 2021;592:120051.","journal-title":"Int J Pharm"},{"key":"2930_CR71","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2217\/nnm109","volume":"5","author":"C Mohanty","year":"2010","unstructured":"Mohanty C, Acharya S, Mohanty AK, Dilnawaz F, Sahoo SK. Curcumin-encapsulated MePEG\/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy. Nanomedicine. 2010;5:433\u201349. https:\/\/doi.org\/10.2217\/nnm109.","journal-title":"Nanomedicine"},{"key":"2930_CR72","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.foodchem.2019.04.077","volume":"293","author":"K Tai","year":"2019","unstructured":"Tai K, Rappolt M, He X, Wei Y, Zhu S, Zhang J, et al. Effect of \u03b2-sitosterol on the curcumin-loaded liposomes: Vesicle characteristics, physicochemical stability, in vitro release and bioavailability. Food Chem. 2019;293:92\u2013102.","journal-title":"Food Chem"},{"key":"2930_CR73","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2174\/1566524018666180416101522","volume":"18","author":"A Jain","year":"2018","unstructured":"Jain A, Jain SK. Advances in tumor targeted liposomes. Curr Mol Med. 2018;18:44\u201357.","journal-title":"Curr Mol Med"},{"key":"2930_CR74","doi-asserted-by":"publisher","first-page":"338","DOI":"10.2174\/138920012800166490","volume":"13","author":"Y Wang","year":"2012","unstructured":"Wang Y, Gou M, Gong C, Wang C, Qian Z, Feng Lin Y, et al. Pharmacokinetics and Disposition of nanomedicine using biodegradable PEG\/PCL polymers as drug carriers. Curr Drug Metab. 2012;13:338\u201353.","journal-title":"Curr Drug Metab"},{"key":"2930_CR75","doi-asserted-by":"publisher","first-page":"34481","DOI":"10.1021\/acsomega.3c02901","volume":"8","author":"K Rathnayake","year":"2023","unstructured":"Rathnayake K, Patel U, Hunt EC, Singh N. Fabrication of a dual-targeted liposome-coated mesoporous silica core-shell nanoassembly for targeted cancer therapy. ACS Omega. 2023;8:34481\u201398.","journal-title":"ACS Omega"},{"key":"2930_CR76","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11095-013-1135-z","volume":"31","author":"AP Costa","year":"2014","unstructured":"Costa AP, Xu X, Burgess DJ. Freeze-anneal-thaw cycling of unilamellar liposomes: Effect on encapsulation efficiency. Pharm Res. 2014;31:97\u2013103.","journal-title":"Pharm Res"},{"key":"2930_CR77","doi-asserted-by":"publisher","first-page":"e0199867","DOI":"10.1371\/journal.pone.0199867","volume":"13","author":"B Sydykov","year":"2018","unstructured":"Sydykov B, Oldenhof H, Sieme H, Wolkers WF. Storage stability of liposomes stored at elevated subzero temperatures in DMSO\/sucrose mixtures. PLoS ONE. 2018;13:e0199867.","journal-title":"PLoS ONE"},{"key":"2930_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-416020-0.00001-2","volume":"104","author":"E Elizondo","year":"2011","unstructured":"Elizondo E, Moreno E, Cabrera I, C\u00f3rdoba A, Sala S, Veciana J, et al. Liposomes and Other Vesicular Systems: Structural Characteristics, Methods of Preparation, and Use in Nanomedicine. Prog Mol Biol Transl Sci. 2011;104:1\u201352.","journal-title":"Prog Mol Biol Transl Sci"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-02930-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-024-02930-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-02930-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T11:08:12Z","timestamp":1729681692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-024-02930-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":78,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["2930"],"URL":"https:\/\/doi.org\/10.1208\/s12249-024-02930-7","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,17]]},"assertion":[{"value":"30 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"216"}}